Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: Heartflow sues Cleerly | PFA & strokes | FDA's warning for cath labs | Stryker & Stereotaxis make moves

News You Need to Know Today
Week in Review: Heartflow sues Cleerly | PFA & strokes | FDA's warning for cath labs | Stryker & Stereotaxis make moves
Saturday, April 18, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 

READ MORE >
AI lawsuit court legal
Share on Twitter Share on Facebook Share on Linkedin

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

Share on Twitter Share on Facebook Share on Linkedin
AI lawsuit court legal
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 
READ MORE >

Long-term antidepressant use may increase risk of sudden cardiac death

The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Long-term antidepressant use may increase risk of sudden cardiac death

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.
READ MORE >

PFA associated with heightened stroke risk

PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment. 

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

PFA associated with heightened stroke risk

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment. 
READ MORE >

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about cath lab procedure kits due to risk of patient injury

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.
READ MORE >

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI model for detecting signs of cardiac amyloidosis

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.
READ MORE >

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.

READ MORE >
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
Share on Twitter Share on Facebook Share on Linkedin

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

Share on Twitter Share on Facebook Share on Linkedin
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.
READ MORE >

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems

Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy. 

READ MORE >
AVS Pulse IVL
Share on Twitter Share on Facebook Share on Linkedin

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems

Share on Twitter Share on Facebook Share on Linkedin
AVS Pulse IVL
Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy. 
READ MORE >

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 
READ MORE >

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

READ MORE >
Robocath acquired by Stereotaxis
Share on Twitter Share on Facebook Share on Linkedin

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

Share on Twitter Share on Facebook Share on Linkedin
Robocath acquired by Stereotaxis
The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.
READ MORE >

FDA approves fast-acting heart drug for children

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.

READ MORE >
pediatric patient young patient child chlidren kid
Share on Twitter Share on Facebook Share on Linkedin

FDA approves fast-acting heart drug for children

Share on Twitter Share on Facebook Share on Linkedin
pediatric patient young patient child chlidren kid
Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR or SAVR? A closer look at those decisions | New Impella 5.5 data | First patient enrolled in massive heart failure trial
Teen's death at center of new lawsuit | Surgery outperforms GLP-1 drugs | Long-term antidepressant use & SCD
AI helps 3D imaging labs evolve | Catheters recalled over safety risk | New ways to predict TAVR outcomes
Looking Back: Cardiologist fired for speaking out | Hospital sues practice | Strokes after PFA | Energy drinks & heart disease
Surgery outperforms GLP-1 drugs | CEPDs fail to make an impact | Redo TAVR: Supra-annular vs. intra-annular valves
Week in Review: FDA clears imaging platform | Vascular device linked to deaths | GLP-1 drugs & AFib | Pacemakers recalled again
Optimism about cardiology’s future | HRS leader looks ahead | Women live longer after TAVR | J&J announces acquisition

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …7
    • Page 8
    • Page 9
    • Page 10
    • Current page 11
    • Page 12
    • Page 13
    • Page 14
    • Page 15 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup